InvestorsObserver
Sign Up Login

MNMD Mind Medicine Mindmed Inc

$0.71 $0.00 (0.00%)
Add to Watchlist Compare
Overall

MNMD Stock Analysis Overview

What this means: Mind Medicine Mindmed Inc (MNMD) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. MNMD's 53 means that it ranks higher than 53% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

MNMD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

MNMD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

MNMD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

MNMD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

MNMD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

MNMD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

MNMD Stock Analysis Overview

What this means: Mind Medicine Mindmed Inc (MNMD) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. MNMD's 53 means that it ranks higher than 53% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full MNMD report

MNMD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

MNMD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

MNMD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

MNMD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

MNMD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

MNMD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Mind Medicine Mindmed Inc (MNMD) Analyst Forecast

MNMD Price, Volume, Earnings, and Dividend Date

  • Last Price $0.71
  • Previous Close $0.71
  • Change $0.00
  • Open $0.79
  • Volume 2,488,000
  • Avg. Volume (100-day) 3,887,837
  • Market Cap 301,851,540
  • Days Range 0.705 - 0.79
  • 52-week Range 0.7 - 4.04
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 08/14/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 1.489
  • PEG Ratio —

Mind Medicine Mindmed Inc (MNMD) Company Description

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Mind Medicine Mindmed Inc (MNMD) Stock Chart

View Interactive MNMD chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Veru Inc (VERU) (VERU) $15.01
SC Pharmaceuticals Inc (SCPH) (SCPH) $4.80
Trevi Therapeutics Inc (TRVI) (TRVI) $2.24
Vaxcyte Inc (PCVX) (PCVX) $24.03
Fennec Pharmaceuticals Inc (FENC) (FENC) $5.97
Adma Biologics (ADMA) (ADMA) $2.01
Foghorn Therapeutics Inc (FHTX) (FHTX) $11.60
Concert Pharmaceutic (CNCE) (CNCE) $4.79
Bellus Health Inc (BLU) (BLU) $8.80
Crinetics Pharmaceuticals Inc (CRNX) (CRNX) $19.91